Introduction
============

Graying of hair is a physiological process that occurs with age in both men and women. The evidence that graying of hair can occur due to oxidative stress ([@R1],[@R2]) has led to the investigation of premature graying as a risk factor for age-related pathologies such as coronary artery disease (CAD) and osteoporosis. Oxidative stress induces ectopic differentiation of melanocytic stem cells thus reducing the stem cell pool that can replace apoptotic melanogenic melanocytes ([@R2],[@R3]). There is a rising trend of CAD among younger people (age≤45 years) in the Indian subcontinent. Smoking plays a dominant role in the etiopathogenesis of CAD among the young ([@R4]). One of the earliest clinical signs which may possibly help in recognizing early onset of CAD in a young smoker is the presence of premature graying of hair. Although this sign was described as early as in 80\'s by Eisentein et al ([@R5],[@R6]) and later few studies from our centre have also shown similar results ([@R7],[@R8]), it has become a subject of intense research only very recently in the western world ([@R9]).

Although some studies have favoured premature graying of hair as a risk factor for CAD, others have not found such an association. The literature search has not revealed any study that assessed premature graying of hair as an independent marker of CAD in smokers. Thus, we need to recognize the early markers of CAD in smokers so that smokers could be persuaded to quit smoking and/or tobacco at the earliest before the disease manifests clinically.

With this background in mind, this study was planned to determine the association between premature graying of hair and CAD in smokers.

Material and Methods
====================

Young patients (\< 45 years of age) were recruited from the Coronary Care Unit and Outpatient Department of a tertiary care centre for this study. The study was duly approved by the Institutional Ethical Committee of the College. The period of study was from July 2011 to June 2012. The patients were recruited on consecutive basis if they fulfilled the inclusion criteria. The patients were divided into two groups. Group I of 62 consecutive young smokers without clinical evidence of CAD and group II of 60 consecutive young CAD smokers presenting with the first episode of acute coronary syndrome. A control group (Group III) comprising of 114 patients (≤45 years) was enrolled from the Outpatient Department. All subjects were males. Informed consent was obtained from all the patients before recruitment for the study. A detailed history regarding smoking habit as well as alcohol use and clinical examination for the presence of graying of hair (more than 25% of scalp and/or beard) was carried out. Waist circumference and blood pressure were also recorded in each study subject. A comprehensive cardiac examination, electrocardiogram (ECG), fasting, and post-prandial blood glucose and lipid profile were also done in both groups. Besides this, carotid intima media thickness was measured in all cases as a surrogate marker of atherosclerosis.

The diagnosis of CAD was made by the treating physician on the basis of history, clinical examination, ECG, cardiac enzymes and/or echocardiography based on the principles of standard WHO criteria ([@R10]). Hypertension was diagnosed according to JNC VIII criteria ([@R11]). Smoking was defined as continuous use of beedi, cigarette and/or any form of tobacco. Consumption of 1 gram of smokeless tobacco was taken as equivalent of one cigarette ([@R12]). A 25% or more graying of hair on scalp and/or beard on visual inspection was taken as a positive criterion for graying in the patient ([@R9]).

Dyslipidemia was defined as per national cholesterol education programme-adult treatment panel III guidelines ([@R13]). Diabetes mellitus, impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) were defined as per American Diabetic Association (ADA) criteria ([@R14]).

Waist circumference was measured midway between subcostal margin and superior iliac spine in the erect position, with the abdomen relaxed the arms at the sides and the feet together. Waist ≥90 cm in males and ≥80 cm in females was considered as evidence of central obesity ([@R15]).

Carotid-artery Intima Media Thickness (CIMT) was determined in all study subjects by a high resolution B-mode ultrasonography system (P-700, PHILIPS). Note was made regarding the location and echo characteristics of the plaque/thickening, luminal narrowing and/or calcification if any. The measurements were made in common carotid and internal carotid artery after the bulb on either side. All scanning was conducted by trained ultrasonologist who was unaware of the clinical status of the study subjects.

Exclusion criteria comprised of older patients (\>45 yrs), known CAD, hypertrophic obstructive cardiomyopathy, severe left ventricular failure (Killips Class IV), advanced renal/hepatic derangements, multi organ failure, severe anaemia (Hb \<6 g/dl) and who had already undergone cardiac surgery/angioplasty.

The statistical analysis was done using SPSS software 20.0 using one way ANOVA test, Tukey\'s test, chi square, Fisher\'s exact test, multivariate logistic regression and unpaired-t test. Logistic regression analysis was also performed on risk factors.

Results
=======

The mean value as well as standard error of risk factors among all subjects in each group is summarized in [table 1](#T1){ref-type="table"}.

###### 

Comparative table of coronary risk factors among different groups along with their 'p' values

  -----------------------------------------------------------------------------------------------------------------------------
                                                           Group 1\          Group 2\          Group 3\           p-value\
                                                           (young smokers\   (young smokers\   (young non\        (Between\
                                                           without CAD)\     with CAD)\        smokers without\   groups as\
                                                           (n=62)            (n=60)            CAD)\              specified)
                                                                                               (n=114)            
  -------------------------------------------------------- ----------------- ----------------- ------------------ -------------
  Age ( years)                                             34.47±6.69        38.77±5.72        32.37±7.99         1vs2=.003\
                                                                                                                  1vs3=.152\
                                                                                                                  2vs3=.000

  SBP[\*](#TF1){ref-type="table-fn"}( mm hg)               119.40±2.18       128.18±2.31       122.06±1.64        1vs2=.019\
                                                                                                                  1vs3=.989\
                                                                                                                  2vs3=.111

  DBP[\*](#TF1){ref-type="table-fn"}( mm hg)               77.58±1.47        75.67±1.56        81.15±1.11         1vs2=1.000\
                                                                                                                  1vs3=.159\
                                                                                                                  2vs3=.017

  PP BG[\*](#TF1){ref-type="table-fn"}( mg/dl)             115.25±3.54       141.10±6.76       121.84±4.67        1vs2=.001\
                                                                                                                  1vs3=.568\
                                                                                                                  2vs3=.008

  FBG[\*](#TF1){ref-type="table-fn"}( mg/dl)               92.58±5.08        99.20±7.40        95.11±6.83         1vs2=.328\
                                                                                                                  1vs3=.792\
                                                                                                                  2vs3=.592

  TC[\*](#TF1){ref-type="table-fn"}(mg/dl)                 150.23±5.79       155.07±6.14       168.75±4.36        1vs2=1.000\
                                                                                                                  1vs3=.034\
                                                                                                                  2vs3=.236

  LDL[\*](#TF1){ref-type="table-fn"}(mg/dl)                84.13±4.74        97.50±5.03        107.25±3.57        1vs2=.163\
                                                                                                                  1vs3=.000\
                                                                                                                  2vs3=.376

  HDL[\*](#TF1){ref-type="table-fn"}(mg/dl)                38.24±1.46        35.72±1.55        41.99±1.10         1vs2=.712\
                                                                                                                  1vs3=.123\
                                                                                                                  2vs3=.004

  TG[\*](#TF1){ref-type="table-fn"}(mg/dl)                 114.22±7.94       120.99±8.42       132.76±5.99        1vs2=1.000\
                                                                                                                  1vs3=.190\
                                                                                                                  2vs3=.806

  R CIMT[\*](#TF1){ref-type="table-fn"}(mm)                0.55±0.01         0.55±0.02         0.48±0.01          1vs2=1.000\
                                                                                                                  1vs3=.001\
                                                                                                                  2vs3=.001

  L CIMT[\*](#TF1){ref-type="table-fn"}(mm)                0.58±0.02         0.56±0.02         0.48±0.01          1vs2=1.000\
                                                                                                                  1vs3=.000\
                                                                                                                  2vs3=.000

  Average CIMT[\*](#TF1){ref-type="table-fn"}(mm)          0.55±0.01         0.56±0.02         0.48±0.01          1vs2=1.000\
                                                                                                                  1vs3=.000\
                                                                                                                  2vs3=.000

  Waist circumference[\*](#TF1){ref-type="table-fn"}(cm)   83.69±1.50        87.78±1.60        81.58±1.13         1vs2=.191\
                                                                                                                  1vs3=.783\
                                                                                                                  2vs3=.007

  Subjects with Graying of hair (n)                        28                46                33                 1vs2=0.000\
                                                                                                                  1vs3=0.031\
                                                                                                                  2vs3=0.000
  -----------------------------------------------------------------------------------------------------------------------------

\- Adjusted for age, p value significant at \< 0.05

CAD = Coronary artery disease, DBP= Diastolic blood pressure, FBG= Fasting blood glucose, HDL= High-density lipoprotein, HT = Hypertension, LDL = Low-density lipoprotein, PPBG= Post prandial blood glucose, SBP= Systolic blood pressure, TC= Total cholesterol, TG= Triglycerides, CIMT= Carotid intima media thickness

The carotid intima media thickness of right, left and common carotid artery in smokers as well as non CAD smokers with CAD (Group I and II) was significantly higher than the control group (Group III).

Dyslipidemia and blood pressure were also significantly higher in group I and II as compared to group III.

When the groups were compared for graying of hair, it was found that the group II (i.e. smokers and CAD) had maximum incidence of graying which was significantly higher than the control as well as smoker group. However, the smokers also had a significantly higher proportion of graying than the control group.

[Table 2](#T2){ref-type="table"} shows the prediction of association of CAD in the study population as calculated by multiple logistic regression analysis. The presence of premature graying of hair was associated a 3.24 times increased risk of CAD.

###### 

Prediction of association of CAD in study population of young smokers with various risk factors using multiple logistic regression analysis

  ----------------------------------------------------------------------------
  Independent\          Odds Ratio (95%\    [†](#TF2){ref-type="table-fn"} p
  variables             CI)                 
  --------------------- ------------------- ----------------------------------
  Age, (years)          1.10 (1.03--1.17)   0.002

  HT                    1.94 (0.86--4.38)   0.108

  DM                    1.73 (0.56--5.33)   0.341

  LDL, mg/dl            1.00 (0.99--1.01)   0.703

  HDL, mg/dL            1.94 (0.93--0.99)   0.019

  Triglyceride, mg/dL   1.00 (0.99--1.00)   0.58

  Graying of hair       3.24 (1.52--6.88)   0.002
  ----------------------------------------------------------------------------

Logistic regression with Enter method

**Dependent variables** = Presence of CAD,

**Independent variables**=Age, HT, DM, LDL cholesterol, Triglyceride, Graying of hair

CAD= coronary artery disease, CI=confidence interval, DM= diabetes mellitus,

HDL= high-density lipoprotein, HT=hypertension, LDL= low-density lipoprotein

Discussion
==========

The present study demonstrated that CIMT measurements and dyslipidemia were significantly different from the control group compared to smokers alone as well as with CAD. When the three groups were compared with respect to graying of hairs, it was found that graying present in the groups of smokers and CAD, was significantly higher than smokers alone as well as controls ([Fig 1](#F1){ref-type="fig"}). It was also found that graying of hairs was independently related to risk of coronary artery disease.

![A 42 years old man, chronic smoker and suffered acute coronary event. Note is made of premature graying of hair](EJHS2502-0123Fig1){#F1}

The molecular and cellular mechanism for loss of pigmentation of hair includes attenuation of enzymes involved in melanogenesis, impaired DNA repair, loss of telomerase and antioxidant mechanisms ([@R17]--[@R22]). Atherosclerosis includes oxidant stress, androgens, inflammatory process and senescence of functioning cells. Thus, atherosclerosis and graying of hair share a similar mechanism. Apart from various changes, smoking also produces typical facial changes of premature ageing, premature graying of hair and wrinkles. The incidence of atherosclerotic disease increases with age as is the case with graying of hair. The mammalian hair follicle contains numerous stem cells. These cells produce melanocytes, which give hair its color. The death or dysfunction of the melanocyte stem cells causes the onset of graying ([@R23]). These stem cells express CD34 just as the vascular system ([@R24]). Today, it is known that cardiovascular risk factors, especially in combination, cause premature atherosclerosis. Similar to their effects on endothelium and circulating progenitor stem cells they may lead to premature and intense hair graying by possible interactions on follicular epithelium and resident stem cells ([@R24], [@R25]).

Our study is also in concurrence with a recent literature showing coronary atherosclerotic burden independently related to hair-graying score. In addition, hair-graying intensity was also associated with age, hyperlipidemia and family history of CAD and creatinine levels ([@R9]).

The present study has a few limitations as it was a retrospective study done only in males. The study did not take into account the effect of amount of smoking and degree of dyslipidemia and diabetes. The sample size was also small. Despite these limitations, our study explored the possibility of graying of hair as an independent marker of CAD especially in young smoker population.

In conclusion, the present study disclosed an association between premature graying of hair and development of CAD in smokers as well as non-smokers. The study postulates that the presence of cutaneous clinical markers like premature graying of hair can be used as preliminary evidence by clinicians for classifying patients at risk for premature CAD especially in smokers. This important sign can be used as a tool for persuading the smokers to quit smoking at the earliest opportunity. Further, a prospective study can be planned to devise a scoring system specific for Indian patients at higher risk for young CAD.
